Literature DB >> 16761003

Bone loss goes beyond estrogen.

T John Martin, Dana Gaddy.   

Abstract

Mesh:

Substances:

Year:  2006        PMID: 16761003     DOI: 10.1038/nm0606-612

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  11 in total

Review 1.  Reproductive hormones and bone.

Authors:  Kristy M Nicks; Tristan W Fowler; Dana Gaddy
Journal:  Curr Osteoporos Rep       Date:  2010-06       Impact factor: 5.096

2.  The endogenous selective estrogen receptor modulator 27-hydroxycholesterol is a negative regulator of bone homeostasis.

Authors:  Carolyn D DuSell; Erik R Nelson; Xiaojuan Wang; Jennifer Abdo; Ulrike I Mödder; Michihisa Umetani; Diane Gesty-Palmer; Norman B Javitt; Sundeep Khosla; Donald P McDonnell
Journal:  Endocrinology       Date:  2010-05-25       Impact factor: 4.736

Review 3.  Our approach to osteoporosis screening and treatment needs to change.

Authors:  Mark S Cooper
Journal:  CMAJ       Date:  2008-06-17       Impact factor: 8.262

4.  Amount of bone loss in relation to time around the final menstrual period and follicle-stimulating hormone staging of the transmenopause.

Authors:  MaryFran R Sowers; Huiyong Zheng; Mary L Jannausch; Daniel McConnell; Bin Nan; Sioban Harlow; John F Randolph
Journal:  J Clin Endocrinol Metab       Date:  2010-03-09       Impact factor: 5.958

Review 5.  Oncogenic role of leptin and Notch interleukin-1 leptin crosstalk outcome in cancer.

Authors:  Crystal C Lipsey; Adriana Harbuzariu; Danielle Daley-Brown; Ruben R Gonzalez-Perez
Journal:  World J Methodol       Date:  2016-03-26

6.  Follicle-stimulating hormone increases bone mass in female mice.

Authors:  Charles M Allan; Robert Kalak; Colin R Dunstan; Kirsten J McTavish; Hong Zhou; David J Handelsman; Markus J Seibel
Journal:  Proc Natl Acad Sci U S A       Date:  2010-12-13       Impact factor: 11.205

7.  Bone phenotypes in response to gonadotropin misexpression: the role for gonadotropins in postmenopausal osteoporosis.

Authors:  Jason P Mansell
Journal:  Int J Gen Med       Date:  2008-11-30

8.  Mechanical strain regulates osteoblast proliferation through integrin-mediated ERK activation.

Authors:  Yu-xian Yan; Yuan-wei Gong; Yong Guo; Qi Lv; Chun Guo; Yan Zhuang; Yuan Zhang; Ruixin Li; Xi-zheng Zhang
Journal:  PLoS One       Date:  2012-04-23       Impact factor: 3.240

Review 9.  FSH and TSH in the regulation of bone mass: the pituitary/immune/bone axis.

Authors:  Graziana Colaianni; Concetta Cuscito; Silvia Colucci
Journal:  Clin Dev Immunol       Date:  2013-05-30

10.  Pharmacological estrogen administration causes a FSH-independent osteo-anabolic effect requiring ER alpha in osteoblasts.

Authors:  Sebastian Seitz; Johannes Keller; Arndt F Schilling; Anke Jeschke; Robert P Marshall; Brenda D Stride; Tim Wintermantel; Frank T Beil; Michael Amling; Günther Schütz; Jan Tuckermann; Thorsten Schinke
Journal:  PLoS One       Date:  2012-11-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.